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Abstract 
The PEGylation process is a covalent attachment between a protein (the pharmaceutical) and 
poly ethylene glycol (PEG) and since the beginning in 1977 PEGylation processes have been 
used to improve pharmaceuticals. PEGylation of a pharmaceutical achieves improved proper-
ties like greater solubility in water, longer residence time in vivo and extended shelf life. 
The PEGylation process is in general conducted with a batch reactor connected to a size ex-
clusion chromatography (SEC) column or more common an ion exchange chromatography 
(IEC) column. The batch reactor achieves a yield of monoPEGylated protein at approximately 
60 % and a 10 % yield of multiPEGylated proteins. Other processes are still under develop-
ment like the size exclusion reaction chromatography (SERC).  
The report contains two parts, an experimental part and a simulation part. The experimental 
section tests the batch reactor in order to calibrate the kinetic constants. Experiments with a 
SERC column were also conducted. The simulation section created models for the batch reac-
tor, the SEC column and the SERC column. The batch reactor model includes four reactions, 
three PEGylation reactions and one deactivation reaction. Both the SEC column and the 
SERC column are described with the General rate model. The SERC column is combined 
with a recirculation cycle and optimized for different objectives.  
The experimental results show fast kinetic reactions for the PEGylation that is suitable for the 
SERC column. The SERC column experiments resulted in a selective monoPEGylated protein 
production. The simulations resulted in a monoPEGylated protein yield at 82.3 % when recir-
culating the unPEGylated protein nine times.  
In future research a more detailed recirculation cycle can be simulated and validated with ex-
periments. Also an automated injection loop where the reactants are mixed when entering the 
SERC column is able to improve the results. 
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1 Introduction 
1.1 Background 
The PEGylation research started in 1977 by Abuchowski et al. (1). The research showed that 
covalent attachment between poly ethylene glycol and bovine liver catalase improved multi-
ple properties of the native protein, such as greater solubility in water, longer residence time 
in vivo and extends shelf life. (1,2)  
In 1990, the first PEGylated product reached clinical practice, PEG-adenosine deaminase 
(Adagen®) against severe combined immunodeficiency disease (SCID). Between 1990 and 
2011 a total of ten PEGylated products were approved for clinical practice fighting diseases 
such as Leukemia and Hepatitis C. The number of approved PEGylated pharmaceuticals will 
increase due to high interest among pharmaceutical companies. (3)  
A major disadvantage with the PEGylation process is the many mixtures of PEGylated pro-
teins given in the reaction. The PEG polymers often have the possibility to attach to the pro-
tein in multiple free sites resulting in multiPEGylated proteins. This means that after a batch 
reaction process a number of different PEGylated proteins plus the native protein will exist 
together with the product. Although these different types of PEGylated proteins are easy to 
separate, a large amount of native protein will still go to waste in the process. (2,4)     
Today the PEGylation process is carried out with a batch reactor and the products are separat-
ed with either an ion exchange chromatography or a size exclusion chromatography. There is 
a lot of research to improve the yield and selectivity, and one of the new ideas are to separate 
the reactants for the product before the products can PEGylate further. This can be done in a 
size exclusion reaction chromatography column. (5) 
1.2 Aim 
The report contains two parts, an experimental and a simulated. The experimental chapter will 
focus on reproducing the batch PEGylation reaction of Maiser et al. (6) using mPEG-
propionaldehyde and Lysozyme in purpose of finding a reaction model. The experimental 
chapter will also include experiments with combine reaction and separation in a size exclusion 
chromatography column. 
The simulation section will start with calibration of the kinetic constants and the porosity con-
stants from the experimental results. Three models are constructed, one batch reactor model, 
one size exclusion chromatography column model and one size exclusion reaction chromatog-
raphy column model. The models will be validated against the experimental data. The SERC 
model is then used in an optimization problem where different objectives are calculated. 
The hypothesis of the report is that recirculation of Lysozyme combined with the size exclu-
sion reaction chromatography column will give a highly selective monoPEGylated protein 
reaction without lowering the yield.   
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2 Theory 
2.1 PEG-chain 
Poly ethylene glycol (PEG) is a neutral polymer, which in its most common configuration 
(Figure 2.1) is a linear polyether that is terminated with a hydroxyl group in each end. PEG 
has a high solubility in both aqueous and organic solvents which makes it a highly versatile 
molecule in biological chemistry. Other important properties are that the polymer is non-
toxic, non-immunogenic and easy to control the molecular weight and applying a large range 
of functional groups. (7–10) Because of the high solubility PEG is able to take up a large 
amount of water giving the molecule a larger viscosity radius. This means that a molecule 
with a specified molecular weight in a size exclusion chromatography column is seen much 
larger. (2,8)  
 
Figure 2.1: Poly ethylene glycol in the most common form where n is equal a positive integer. 
In the PEG molecule’s common state the molecule have a low reactivity against other mole-
cules. In order to be able to use PEG in various reactions it must be activated with a functional 
group at one or both ends. The activation processes have been divided into two generations. In 
the first generation, PEG-chains are often affected with negative properties such as impurities, 
low molecular weights and unstable linkage. In PEGylation the first generation PEG chains 
are attached to either the alpha or epsilon amino groups for example PEG dichlorotriazine, 
PEG trichlorophenyl carbonate and PEG succinimidyl succinate (PEG-NHS seen in Figure 
2.2). (7,11)   
 
Figure 2.2: A typical first generation PEG chain. This molecule is called PEG-NHS. 
In the second generation, PEG chains are produced to avoid the first generation inadequacies. 
One of the first examples is the first generation PEG chain PEG-acetaldehyde that was substi-
tuted with the second generation PEG chain mPEG-propionaldehyde (Figure 2.3). This ex-
change resulted in prevention of impurities by aldol condensation. Another improvement with 
the most second generation PEG chains is the extension of the chain giving an increase in 
half-life. (7,11)   
 
Figure 2.3: One of the first second generation PEG chains used in experiments. This molecule 
is also used in the experiments later in the report. 
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2.2 Reducing agent 
A reducing agent is necessary in order to complete a PEGylation reaction between a protein 
and mPEG aldehydes. The reducing agent has an amount of requirements that must be ful-
filled. One requirement is that the reducing agent needs to be selective and reduce the correct 
functional group. The most common reducing agent used in PEGylation processes is sodium 
cyanoborohydride, NaCNBH3. (12,13) 
Sodium cyanoborohydride is used in the PEGylation process because of a couple of proper-
ties. The major property is that sodium cyanoborohydride is effective in attaining a site specif-
ic PEGylation. Other properties are that sodium cyanoborohydride is highly soluble in aque-
ous solutions, tough and efficient reducing agent. The drawback with using sodium cyanobo-
rohydride is that the reduction reaction produces very toxic hydrogen cyanide. (12,13) 
Research to find a reducing agent with the same properties as sodium cyanoborohydride is 
largely conducted due to its highly toxic byproduct. Many types of borane class agents have 
been tested due to the borane molecules ability to selectively reduce specific functional 
groups. Similar results shows when PEGylating the Recombinant human interleukin 10 pro-
tein with the reducing agents pyridine borane and 2-picoline borane compared with results 
when PEGylating with sodium cyanoborohydride. (13) 
2.3 Size exclusion chromatography 
Size exclusion chromatography (SEC) separates molecules according to size. The separation 
can be achieved due to porous particles packed inside the column. Large molecules can only 
access the volume outside the particles (void volume) and small molecules can access both 
the void volume and the particle pores (Figure 2.4). Large molecules will therefore travel 
faster through the column and smaller molecules will follow according to size. (14) 
The SEC columns possibility to separate molecules is determined by the particles pore size 
and column length. Large pore sizes (~100 nm) have the ability to separate molecules up to 
1,500,000 Da and small pore sizes (~5 nm) have the ability to separate molecules up to 5000 
Da. The closer the different molecules are according to size the longer the column is needed 
to get a satisfying separation. To be able to separate a wide range of molecule sizes a column 
packed with particles with different pore sizes is preferable. (14)  
The SEC column is an excellent choice for the separation part of the PEGylation process. Due 
to the high molecular weight of the PEG chains it is possible to separate the different 
PEGylated proteins from each other and the native protein. Another advantage with the PEG 
chains combined with SEC is that PEG chains appear larger than its real molecular weight. As 
mentioned before PEG chains have the possibility to bind water and therefore achieve larger 
viscosity radiuses which in a SEC column will look like the PEG chain have a much larger 
molecular weight. This makes it possible to separate PEGylated proteins with high accuracy 
even though a small PEG chain is used. (15)   
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Figure 2.4: The figure shows how molecules with different sizes flow through the size exclu-
sion column. Large molecules avoid the particles and smaller molecules diffuse in to the 
pores of the particles. 
2.4 PEGylation reaction 
The PEGylation reaction is a covalent attachment of PEG to a protein or a peptide. The most 
common reaction is between PEG and an active N-terminal amino group (Figure 2.5). Exam-
ple of some amino acids which is used in the PEGylation is lysine, arginine, glutamic acid, 
serine and tyrosine. Lysine is one of the most frequent amino acid in proteins and therefore 
often chosen to connect with the PEG chains. Lysine also have two possible N-terminals, al-
pha and epsilon amino groups. Other ways to PEGylate is through the C-terminal carboxylic 
acid and when using glycoproteins two close hydroxyl groups are oxidized. (7,16,17) 
 
Figure 2.5: This is the main reaction for the PEGylation reaction between a mPEG-aldehyde 
and the active lysine part of the protein. 
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Due to the possibility for PEG chains to attach to multiple sites of the protein the finished 
product could have a mixture of different PEGylated proteins. In the case where lysozyme is 
PEGylated there are three possible active sites resulting in monoPEGylated, diPEGylated and 
triPEGylated protein and seven PEGylated configurations excluding the native protein (Figure 
2.6). (7) 
 
Figure 2.6: In Lysozyme there exist three possible lysine locations for the PEG chain to at-
tach. This gives the multiple reaction pathways to react according to the figure above. 
To fully understand the PEGylation reaction a deeper investigation of the reaction mechanism 
is needed. The reaction mechanism presented below is an example where mPEG-aldehydes 
are covalently attached to an active N-terminal of lysine and reduced with sodium cyanoboro-
hydride in a light acidic environment. This is one of many possible solutions to successfully 
PEGylate a protein. (7,16,17) 
The first step of the mechanism is that the active ends of the PEG chain take up a positive 
hydrogen ion (Figure 2.7). The oxygen becomes positive and will draw electrons from the 
carbon giving the active end a dipole moment. (18,19) 
 
Figure 2.7: Step 1 of 8 in the main reaction mechanism. 
The second step is a nucleophilic addition where the N-terminal from lysine attacks the car-
bon (Figure 2.8). The double bond between the carbon and oxygen becomes a single bond and 
the oxygen charge becomes neutral. This step creates the covalent bond between the PEG 
chain and Lysozyme. (18,19) 
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Figure 2.8: The figure describes the second step of the mechanism for the main reaction. 
The third step is an acid/base reaction where the base picks up hydrogen from the nitrogen 
(Figure 2.9). The bond returns to the nitrogen and becomes a free electron pair. (18,19) 
 
Figure 2.9: The figure shows the third step of the mechanism. 
Step four is also an acid/base reaction but this time the base release the hydrogen to the oxy-
gen (Figure 2.10). The oxygen is now carrying two hydrogens and is therefore positively 
charged. (18,19) 
 
Figure 2.10: Step 4 of 8 in the main reaction mechanism. 
In the fifth step the bond between carbon and oxygen is released and the molecule becomes 
dehydrated. At the same time the carbon connects the nitrogen with a second bond by the help 
of the free electron pair from the nitrogen (Figure 2.11). (18,19) 
 
Figure 2.11: The figure illustrates the fifth mechanism step of the main reaction. 
The sixth step of the mechanism is the last reversible reaction step. Here the acid catalyst re-
turns to its original state. A water molecule attacks and takes up the last hydrogen (Figure 
2.12) connected to the nitrogen and therefore neutralizing the positive nitrogen atom. (18,19) 
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Figure 2.12: The figure displays the mechanism step 6 of 8 for the main reaction. 
Step seven is the first irreversible reaction and the step where sodium cyanoborohydride is 
consumed. Sodium cyanoborohydride reduces the carbon atom with hydrogen (Figure 2.13) 
and the double bond decreases to a single bond giving the nitrogen a negative charge. This 
step is assumed to be the rate-determining step of the PEGylation reaction. (18,19) 
 
Figure 2.13: The mechanism step 7 of 8. It’s the first irreversible step of the main reaction 
and also the first step where the reducing agent is used. 
The last step of the mechanism is also an irreversible step. The negative charge of the nitrogen 
atom is neutralized with a hydrogen ion (Figure 2.14) and the PEGylation is now completed. 
(18,19) 
 
Figure 2.14: The last step of the main reaction mechanism. This step is also an irreversible 
reaction. 
At the same time as the PEGylation reaction, a deactivation of the PEG chain occurs. Sodium 
cyanoborohydride have the possibility to reduce the active end in the PEG chains. This is 
done in the same way as step seven and eight of the PEGylation mechanism (Figure 2.15). 
(18,19) 
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Figure 2.15: The figure illustrates the 2-step deactivation reaction between the PEG molecule 
and the reducing agent making the PEG chain unavalible for the PEGylation reaction. 
2.5 PEGylation processes 
2.5.1 Batch reactor process 
The most frequently used PEGylation process is conducted with a batch reactor. The batch 
reactor is preferred due to the often slow reaction kinetics. The batch reactor gives a tradeoff 
whether the user wants a high yield or low concentration of byproducts. A low reaction time 
offers low byproduct (multiPEGylated protein) concentration but the conversions of protein to 
monoPEGylated protein are also low and thus achieve a high amount of unreacted pharma-
ceuticals that will be wasted. (8,20,21) 
After the batch reactor, the products and remaining reactants are separated, either with an ion 
exchange chromatography (IEC) column or with a size exclusion chromatography (SEC) col-
umn.  The benefits with using IEC are that it is easy to clean, have a higher capacity and they 
are smaller than a SEC and thereby making it possible to achieve higher flow rates without 
high pressure drops. A SEC column on the other hand does not need to use high salt concen-
trations. (8,20) 
2.5.2 Combined recirculation process 
To be able to reach a higher yield without producing a large amount of byproducts a recircula-
tion of unreacted protein is sent back to the batch reactor. This makes it possible to stop the 
batch reaction earlier with the result of a low byproduct concentration. The unreacted protein 
is then recycled back to the batch reactor where it can PEGylate again resulting in a higher 
monoPEGylated protein yield. The number of recirculations is however restricted because of 
an unwanted side reaction where the protein slowly forms a degraded version of itself. (21,22) 
2.5.3 Size exclusion reaction chromatography process 
The new interesting process which is still under development is size exclusion reaction chro-
matography (SERC). This method combines reaction and separation in a SEC column. It is 
therefore possible to remove the monoPEGylated protein before it PEGylates another time 
resulting in a higher selectivity for the process. (5,23)  
The process can be performed in two different ways. The first one (Figure 2.16) have a load 
with both reactants. The reactants also have approximately the same molecular weight and 
therefore will the reaction zone move all the way through the column. The product, that will 
have higher molecular weight, will go faster through the column and thereby leaving the reac-
tion zone. (5,23) 
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Figure 2.16: The figure illustrates how the SERC column produces and separates the product 
at the same time. 
The second version of the process (Figure 2.17) is where the reactants have different molecu-
lar weights and therefore moving at different velocities through the column. The load is then 
divided into two, where the reactant with the low molecular weight is injected first. The sec-
ond reactant will have a higher molecular weight resulting in a faster flow that will catch up 
the other reactant. A reaction zone is created during the second loads passing of the first. The 
product that is created in the reaction zone will have a larger molecular weight than the reac-
tants and therefore achieve a greater speed. In the end it is possible to collect both reactants 
and the product separated from each other. (5,23) 
 
Figure 2.17: The figure shows the SERC column when using two reactants with different mo-
lecular weights. 
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3 Materials & Methods 
3.1 Experiments 
3.1.1 Materials 
All the chemicals were obtained from Sigma-Aldrich (Schnelldorf, Germany). The Superdex 
200 10/300 GL SEC column was purchased from GE Healthcare (Uppsala, Sweden). The 
column was connected to an Äkta purifier system from GE Healthcare (Uppsala, Sweden). A 
refractive index detector RID-6A from Shimdzu (Kyoto, Japan) was also used.  
3.1.2 Preparations 
For the Äkta purifier system four solutions were prepared: To clean and preserve the SEC 
column a solution with 1.0 M NaOH and a solution with 20% ethanol were prepared and de-
gassed. The system was also equipped with degassed distilled water. As a buffer for the col-
umn, a degassed solution containing 25 mM sodium phosphate and 150 mM sodium chloride 
was prepared. The reaction buffer containing 40 mM sodium cyanoborohydride and 50 mM 
sodium phosphate was prepared and degassed. 
3.1.3 Batch reactor 
The batch reactor tests were divided into two different experiment types, kinetic and long re-
action time. The long reaction time was used to calibrate the SEC column and the kinetic test 
was used to calibrate the kinetic constants. Each individual test parameters used can be seen 
in the appendix (Table 10.1).   
The long time reaction was mixed with 7.5 ml of Lysozyme (10 mg/ml) and reaction buffer 
solution together with 7.5 ml of 0.1575 g PEG (6:1 PEG to Lysozyme molar ratio) dissolved 
in distilled water. The reaction was then carried out in a 20 ml continuous stirred batch reactor 
and at room temperature. The first sample was taken after 5 min and between one and ten 
hours of reaction time the samples were taken with an hour interval. The last sample was tak-
en after 24 h. Each sample was a total of 0.50 ml. The samples were directly injected to the 
SEC column for analysis. 
The kinetic experiment was divided into four identical experiments. Reaction buffer and 2.5 
ml of Lysozyme (15 mg/ml) were mixed with 0.105 g PEG (8:1 PEG to Lysozyme molar ra-
tio) dissolved in 2.5 ml distilled water. The reactions were carried out in a 7.5 ml continuous 
stirred batch reactor and at room temperature. A total of ten samples were taken under a three 
hour reaction time and directly injected into the SEC column for evaluation. 
3.1.4 Size exclusion chromatography separations 
Column void, particle porosity and dead volume were needed to be tested before the batch 
reaction samples could be analyzed. For the dead volume test a solution with 1.0 mg/ml Ly-
sozyme was injected to the system without a coupled column. The column void and particle 
porosity were tested with the injection of a solution with 1.0 mg/ml Blue DEXTRAN 2000 
and 0.50 % acetone. All the samples were injected to a 100 µl injection loop and transferred 
through the column with the flowrate of 0.50 ml/min. The separation was observed and rec-
orded with UV light at a wavelength of 280 nm. The PEG molecules are not visible with UV 
light and are therefore detected and analyzed with a refractive index detector.    
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3.1.5 Size exclusion reaction chromatography tests 
The SERC experiments were prepared with 1.0 ml of Lysozyme (15 mg/ml) and reaction 
buffer solution mixed together with 0.0420 g PEG dissolved in 1.0 ml distilled water. The 
prepared solution was injected into the SEC column instantly after mixing. The injection loop 
had a volume capacity of 500 µl. The sample flowed through the column with the speed of 
0.30 ml/min. The reaction and separation were observed and recorded in the end of the col-
umn with UV light at a wavelength of 280 nm. Each experiment conducted, can be seen in the 
appendix (Table 10.2). 
3.2 Simulations 
All the simulations were programmed with the computer program Matlab R2013a
®
 
 
(24). To 
solve the differential equations Matlab
®’s built in function ode15s was used. For the kinetic 
calibration another built in function was used: lsqcurvefit. When optimizing the process a set 
of combined functions were used. The foundation used the built in function fminsearch and 
the main function used is fminsearchbnd (25). 
3.2.1 Batch reaction model 
In the simulations of the batch reactor the PEGylation reactions were considered to be of 
pseudo first order irreversible reaction (Equation 1-3). Sodium cyanoborohydride plays an 
important role in the time dependent step of the reactions and was therefore included in the 
reaction equations. The Lysozyme was assumed to be able to PEGylate three times. 
311 CNBHPEGlysozyme
ccckr   (1) 
322 CNBHPEGmonoPEG
ccckr   (2) 
333 CNBHPEGdiPEG
ccckr   (3) 
The simulation also has to take into account the deactivation reaction between the PEG mole-
cule and sodium cyanoborohydride. The deactivation reaction was assumed to be a first order 
reaction (Equation 4). 
344 CNBHPEG
cckr   (4) 
Each substance depends on the reactions according to Equations 5-9. Sodium cyanoborohy-
dride was calculated in the same way as PEG (Equation 9), because both were assumed to be 
consumed in all reactions. 
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 (5-9) 
3.2.2 Size exclusion reaction chromatography model 
The SERC column was simulated using the General rate model. Each substance was individu-
ally calculated to flow through the column void according to Equation 10. The equation takes 
into consideration that the concentrations were dependent on dispersion, convection, pore 
diffusion and reaction along the column length.  
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The dispersion, convection and reaction inside the pores were calculated individually for each 
substance with Equation 11. Equation 11 was simulated simultaneously with Equation 10.   
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The column starts the simulation without any substances inside (empty column). This was 
described with the initial conditions from Equation 12 for the void and Equation 13 for the 
pores. 
  0,0,  ztc ib  ,       0,0,  rtc ip  (12, 13) 
The boundary condition for the beginning of the column was described with a Dirichlet condi-
tion (Equation 14). The end of the column was described with a von Neumann boundary con-
dition (Equation 15).  
  )(0, ,, tcztc iinib    ,    0),(,  Lztc ib  (14, 15) 
The diffusion into the pore can be defined as a Robin boundary condition (Equation 16). In 
the middle of the pore it is assumed no flux which was described with a von Neumann condi-
tion (Equation 17). 
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The dispersion coefficient for the column void was calculated using the Peclét correlation 
(Equation 18) (26). The Peclét number was assumed to be equal to 1.0. 
Pe
dv
D
p
ax

  (18) 
Equation 19, also called the Wilson-Geankopolis correlation, was used to calculate the mass 
transfer coefficient (26). The free diffusivity coefficient was approximated to 10
-6
 for all 
components.  
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The partial differential equations were solved by using the Method of lines (MOL)(27) meth-
od that discretized the column in space. The derivatives inside each element were approxi-
mated with the Finite volume method (FVM) (28). The column was divided into a mesh of 
300 grid points and the particles used a mesh of 10. The dispersion was approximated with a 3 
point central approximation (Equation 20) for both the column and the particle equations. The 
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convection in the pore also used a 3 point central approximation (Equation 21). The convec-
tion in the column used a flux limiter that combined the 3 point central approximation (Equa-
tion 21) with a 2 point backward approximation (Equation 22) to avoid oscillation effects.  
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 (20-22) 
The flux limiter was applied according to Equation 23. When the flux derivatives in column 
were high, a 2 point backward approximation was dominant and when the flux derivatives 
were low, a 3 point central approximation was dominant.  
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The flux limiter function ϕ(s) was calculated with Equation 24 which is the van Albada sym-
metric limiter function. The ϕ(s) function was restricted to only positive values; negative val-
ues were automatically assigned the value zero. s was described as the ratio of sequential gra-
dients in the mesh (Equation 25). A small number was added to avoid the possibility of divi-
sion by zero.  
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3.2.3 Calibrations 
The calibration of the kinetic constants was done with the experimental data from batch reac-
tor test P. The built in function lsqcurvefit used the batch reaction model to optimize the four 
kinetic constants in order that the simulations matched the experimental data. Lsqcurvefit was 
given the following inputs: the function for the batch reaction model, the guessed values for 
each constant, the time and concentrations from the experiments and a lower boundary for 
each constant. The lower boundary was used to ensure that the kinetic constants were as-
signed a positive value. 
The partition coefficient for each PEGylated substance, native protein and PEG were calibrat-
ed with Equation 26. The retention volumes for the substances were calculated using the aver-
age peak maximum from the batch experiment H (Table 10.1 in Appendix) chromatography 
results. The partition coefficient for the PEG molecule was calibrated with the results from the 
refraction index data. The reducing agent was assumed to access the total pore volume. 
ct
ci
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VV
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

,  (26) 
3.2.4 Optimizations 
The optimization of the PEGylation process was done by using the SERC model to calculate 
the amount monoPEGylated protein and native protein at the end of the column. The native 
protein was assumed to be totally separated from the monoPEGylated protein. The native pro-
tein was after the column recirculated back to the SERC column for another PEGylation run. 
The SERC model runs a total of ten times (nine recirculations). The optimization was limited 
by alter two parameters together with the best amount of recirculation steps according to the 
calculated object. The parameters altered were the flow through the column (max 0.75 
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ml/min, min 0.25 ml/min) and the PEG to Lysozyme molar ratio (max 12, min 1). The bound-
aries for the parameters were set according to the regulations from the manual for the SEC 
column. The objective for the optimization was calculated with multiple equations to get an 
overview of possible solutions.   
The first objective was calculated with Equation 27. The objective was to minimize the 
amount of PEG molecules needed to produce one monoPEG molecule. The equation avoids 
the possibility of achieving the result with no production by dividing the mole fraction of 
monoPEG with the so called total PEG to monoPEG molar ratio.  
1)()( 

monoPEGPEG
monoPEG
nn
x
objective  (27)  
Equation 28 was used to calculate the second objective. This objective was created to maxim-
ize the productivity of monoPEGylated protein.  
t
x
objective monoPEG  (28)  
The objective calculated with Equation 29 was able to minimize the waste of native protein. 
Lysozmex
objective
1
  (29)  
In Equation 30 the objective calculated the maximum monoPEG production possible. 
monoPEGxobjective   (30)  
To avoid the production of multiPEGylated protein the Equation 31 was implemented. The 
production of monoPEG was also added to the equation in the same way as Equation 27 to 
avoid zero production. 
multiPEG
monoPEG
x
x
objective   (31)  
The objective in Equation 32 is a combination of productivity, minimize PEG usage and min-
imize the waste of native protein. 
Lysozyme
monoPEG
PEG
monoPEGmonoPEG
x
n
n
x
t
x
objective
1


 (32) 
Equation 33 calculated the objective when combining maximum monoPEG production with 
productivity.  
t
x
xobjective monoPEGmonoPEG  (33) 
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4 Results 
4.1 Experimental results 
The results from the batch reaction show that a fast reaction between Lysozyme and mPEG-
propionaldehyde can be achieved with the concentrations of 7.5 mg/ml Lysozyme, 20 mM 
sodium cyanoborohydride and a 8:1 PEG to Lysozyme molar ratio. The long time reaction 
results confirm that Lysozyme has the possibility of PEGylate three times (Figure 4.1).   
 
Figure 4.1: The figure shows the change of concentrations in the batch reactor. The peaks 
with the start from right are: Lysozyme, monoPEG, diPEG and triPEG. 
The SERC experiments confirm the possibility to conduct a reaction inside the SEC column. 
The separation between native and monoPEGylated protein makes it possible to pool both 
with a yield and purity over 95 %. The reaction in the SERC column is confirmed more selec-
tive in comparison to the batch reaction under these conditions. The same amount of produced 
monoPEG in the batch reactor as the SERC column accumulates more multiPEGylated pro-
tein. 
4.2 Calibration results 
The calibration results for the kinetic constants can be seen in Table 4.1. The constants define 
a decreasing kinetic velocity for each PEGylation of the protein which can be described by 
that the protein becomes less available for the PEG chains in every PEGylation step. 
Table 4.1: The table illustrates the calibrated kinetic constants for the four reactions. 
Constant Value 
k1 5.74 dm
6
/mole
2
s 
k2 3.96 dm
6
/mole
2
s 
k3 3.47 dm
6
/mole
2
s 
k4 0.0282 dm
3
/moles 
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The results from the calibration of the partition coefficients can be seen in Table 4.2. The re-
fraction index experiment confirms that the PEG chains have access to the total pore volume.   
Table 4.2: the table shows the calibrated porosity constants for each substance. 
Substance KD 
Lysozyme 0.978 
MonoPEG 0.626 
DiPEG 0.454 
TriPEG 0.369 
PEG 1.00 
 
4.3 Validation 
4.3.1 Kinetics 
The validation of the kinetic constants is showed in Figure 4.2. The model has a good fit 
against the experimental data. The experimental data is taken from batch reactions P (four 
identical experiments). 
 
Figure 4.2: The figure illustrates the validation of the kinetic constants. 
4.3.2 Size exclusion chromatography 
The partition coefficients are validated with Figure 4.3. The chromatogram used in the figure 
is taken from the 24 h test from batch reaction experiment H. The peaks were well adapted to 
the experimental data. 
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Figure 4.3: The figure illustrates the adaptation of the simulated SEC model against the ex-
perimental data, validating the SEC model. 
4.3.3 Size exclusion reaction chromatography 
The validation of the SERC model is shown in Figure 4.4. The model is considered to have a 
sufficient adaptation against the experimental data. The model also confirms the reaction due 
to approximately the same end concentrations.  
 
Figure 4.4: The figure shows the adaptation of the simulated SERC model against the exper-
imental data, validating the SERC model. The experimental data is taken from SERC reaction 
test Q.  
4.4 Optimization results  
The recirculation of Lysozyme back to the SERC column is shown in Figure 4.5. The simula-
tion also confirms a greater selectivity than the batch reaction. When recirculating more than 
two times an increase in yield compared to the batch reaction is achieved. 
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Figure 4.5: The figure illustrates total molar fraction Lysozyme, monoPEG and multiPEG 
after each recirculation cycle. 
The optimization simulations reach a possible monoPEG yield up to 82.3 % after the ninth 
recirculation (objective equation 29). The simulations also report a maximum multiPEG yield 
of 2.46 %. It can also be shown that it requires a minimum of 41 PEG molecules to produce 
one monoPEGylated protein molecule (objective equation 27). For all optimizations the Ly-
sozyme concentration is fixed at 10 mg/ml. The results from the different optimizations can 
be seen in Table 4.3.   
Table 4.3: The table shows the results from the optimization according to referred equation in 
chapter 3.2.4. The Lysozyme concentration is fixed at 10 mg/ml. 
Objective 
equation 
Flow 
(ml/min) 
PEG: Lyso-
zyme ratio 
PEG: mon-
oPEG ratio 
Recirculation 
MonoPEG 
(%) 
MultiPEG 
(%) 
t (h) 
27 0.25 5.02 41.0 9 68.4 0.866 16.0 
28 0.75 12 60.5 0 19.8 0.320 0.533 
29 0.25 12 55.2 9 82.3 2.46 16.0 
30 0.25 12 55.2 9 82.3 2.46 16.0 
31 0.75 1 55.8 9 16.5 0.0203 5.33 
32 0.25 12 43.5 3 67.4 2.31 6.40 
33 0.75 12 73.8 3 49.3 0.654 2.13 
 
Figure 4.6 is used to validate the optimization for equation 33. Each surface represents the 
objective value for different flowrates and PEG to Lysozyme molar ratios when recirculated a 
specific number of steps.  
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Figure 4.6: The figure shows the optimization when lysozyme has been recirculated zero, 
three, six and nine times. The objective is calculated with equation 33 where three recircula-
tion steps achieve the highest value. The star represents the optimum for three recirculation 
steps, the circle represents zero recirculation steps, the triangle represents six recirculation 
steps and the square represents nine recirculation steps.      
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5 Discussion 
5.1 Experiments 
5.1.1 Batch reactor 
The kinetic reaction was divided into four experiments. A better result would have been 
achieved if all the samples came from the same experiment. This would be possible if the sys-
tem could have been running multiple SEC columns at the same time or something that could 
have stopped the reaction from taking place in the sample. A test where a small amount of 
sodium hydroxide was added to the sample was performed unsuccessfully.  
Another test where the parameters were altered should have been done to further validate the 
kinetic constants. The PEGylated proteins were detected with an UV light at a wavelength of 
280 nm. It is also possible to use wavelengths at 254 nm and 215 nm at the same time to get 
more accurate results.  
5.1.2 Size exclusion reaction chromatography 
The best results from the SERC column were given when the reactants were mixed in the ex-
act moment they entered the column. If the reactants are injected manually (done in the exper-
iments) there will be a residence time up to two minutes where the reactants can react like in 
the batch reactor. This will result in a higher final concentration for both the monoPEGylated 
protein and the multiPEGylated protein.  
5.2 Simulations 
5.2.1 Models 
The batch reactor model assumed four irreversible reactions. This is only validated under a 
three hour period. The 24 hour experiment shows that a reaction still occurs after it theoreti-
cally should have stopped. It is possible that the deactivation reaction of the PEG molecule is 
a reversible reaction. 
Both the SEC model and the SERC model use the general rate model to describe the concen-
trations inside the column. It is also possible to use the dispersion model. The dispersion 
model describes a total void volume accessible for the specific molecule instead of describing 
the diffusion into the pores. In the SEC model case it is possible that the dispersion model is a 
good approximation but in the SERC model case the reactions need more accurate concentra-
tions both in the void and pores. 
The Peclét number, diffusion coefficient and free diffusion coefficient are coefficients that 
have been given an assumed value. All the coefficients are also assumed to be the same value 
for all the substances. The Peclét number can be calibrated with experimental data but it is 
often given a standard value used for macromolecules in packed beds. It is possible to calcu-
late the free diffusion coefficient with the Stoke-Einstein equation or calibrate the value from 
experimental data. Both ways will give specific values for each substance. The diffusion coef-
ficient can also be calibrated from experimental data or estimated with equations.  
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As mentioned before a mixing of the reactants were done before the injection. The SERC 
model does not simulate the reactions that occur before the column. This can be solved with 
either introducing a small batch reactor with a residence time of approximately two minutes 
before the column in the simulations or making an automatic injection loop that have the pos-
sibility of injecting the reactants at the same time to the column in the experiment. 
5.2.2 Optimization 
The optimization applies the assumption that the monoPEGylated protein is fully separated 
from the native protein. The simulation of each recirculation step assumes that the un-
PEGylated protein can be recirculated and purified to match the same load volume as the first 
step. The steps after the column need a separation step where the unPEGylated protein is sep-
arated from the PEG chains and a purification step where the unPEGylated protein is collect-
ed in a total volume matching the original load.   
The optimization uses seven different object equations, each with its own purpose as de-
scribed in the method. The cost objective is one objective that is the most important and not in 
this report. The experiments use Lysozyme (a cheap protein) and a PEG-chain that in compar-
ison to the Lysozyme is an expensive molecule. In real cases is the protein (pharmaceutical) 
the expensive molecule and the PEG-chain is possibly the cheap molecule. This makes it im-
possible to estimate a good cost objective with the available data. A possible solution is to use 
a cost ratio between the molecules.  
5.2.3 Restrictions 
The simulations are restricted by experimental boundaries like viscosity and SEC column 
limits. Lysozyme and the PEG-chain are both large molecules that generate high viscosities 
when increasing the concentrations. The SEC column limits the protein concentration to 10 
mg/ml when using a load of 0.5 ml. The PEG chain concentration is limited to a PEG to Ly-
sozyme molar ratio of 12:1. This limit is chosen because of the extrapolation from the exper-
imental validation. The column flow is restricted to a minimum of 0.25 ml/min and a maxi-
mum of 0.75 ml/min.  
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6 Conclusions 
The experiments confirm that Lysozyme is able to PEGylate three times. The reactions 
achieve a velocity approved for experiments with size exclusion reaction chromatography. 
The batch reaction experiment validates the batch reactor model with three PEGylation reac-
tions and one deactivation reaction. 
The SERC experiment confirms and validates that a reaction can occur inside a SEC column 
as well as improving the reaction selectivity. The best experimental result of monoPEGylated 
protein yield was achieved with a flow at 0.3 ml/min and a load volume of 0.5 ml. 
The calibration of the kinetic constants achieved values of 5.74, 3.96 and 3.47 (dm
6
/mole
2
s) 
for the reactions into monoPEGylation, diPEGylation and triPEGylation respectively. The 
kinetic constant of the deactivation reaction was calibrated to 0.0282 (dm
3
/moles). In the SEC 
column the PEG chains used 100 % of the particle pores. The native, monoPEGylated, di-
PEGylated and triPEGylated protein used 97.8 %, 62.6 %, 45.4 % and 36.9 % respectively of 
the particle pores.    
The optimization shows that it is potential to reach a yield of 82.3 % monoPEGylated protein 
when recirculating the unPEGylated protein nine times. In comparison to the batch reaction 
yield of approximately 40 % monoPEGylated protein the SERC column with recirculation 
have a possibility of doubling the production yield. The amount of multiPEGylated protein 
reaches a maximum yield of 2.46 %, thereby improving the selectivity substantially.   
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7 Future Work 
Future work with an automatized injection where the protein and PEG chain are mixed at the 
same time as they are entering the column could be able to improve the SERC column exper-
iments so that reactions before the column are avoided.  
This work only simulates the SERC column which means that more work about the recircula-
tion loop is needed. Is it possible to extract all the unPEGylated protein and purify it to the 
correct volume? An easy possible solution could be to pool the unPEGylated protein which 
also includes deactivated PEG molecules and run it through an ion exchange chromatography 
column. A purifying step with ultra-filtration after the IEC column is used to lower the total 
volume into the original load volume. 
The experiments use a combination of Lysozyme and mPEG-propionaldehyde with a molecu-
lar weight of 5000 Da. Next step is to use already FDA approved PEGylated pharmaceuticals 
to evaluate the existing process.        
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9 Table of abbreviations 
Symbol Unit Description 
Latin     
c mole/dm
3
 concentration 
Dax m
2
/s dispersion coefficient 
De m
2
/s diffusion coefficient 
DM m
2
/s free diffusion coefficient 
dp m particle diameter  
F - total mesh flux 
f - flux resolution 
h m mesh length 
i - substance index 
k - kinetic constant 
KD - partition coefficient 
kf m/s mass transfer coefficient 
L m column length 
n - mesh index 
ni mole amount of substance 
Pe - Peclét number 
r m particle radius 
rb mole/dm
3
s reaction in bulk 
rp mole/dm
3
s reaction in pore 
s - ratio of successive gradients 
t s time 
v m/s velocity 
Vc ml column void volume 
Vi ml substance column volume 
Vt ml column total volume 
x - molar ratio 
z m column length 
Greek     
εc - porosity of particle bed 
εp - particle porosity 
Φ - flux limiter function 
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10  Appendix 
Table 10.1 The table shows the parameters for each test done with the batch reactor. 
Experiment 
Lysozyme 
conc. (mg/ml) 
PEG molar 
ratio 
PEG type 
NaCNBH3 
conc. (mM) 
Reaction 
time (h) 
Comments 
A 5 6:1 PEG-NHS 2000 g/mole 20 3.5 no reaction 
B 5 3:1 PEG-NHS 5000 g/mole 20 3 no reaction 
C 5 6:1 PEG-NHS 2000 g/mole 20 19.5 no reaction 
D 5 6:1 PEG-NHS 2000 g/mole - 3 
pH 8.5 buffer replaces reducing agent, lyso-
zyme conc. decreasing 
E 5 10:1 PEG-NHS 5000 g/mole - 23 
pH 8.5 buffer replaces reducing agent, lyso-
zyme conc. decreasing 
F 5 6:1 PEG-ald 2000 g/mole 20 5 reaction giving monoPEG and diPEG 
G 5 6:1 PEG-ald 5000 g/mole 20 6 
reaction giving monoPEG, diPEG and 
triPEG 
H 5 6:1 PEG-ald 5000 g/mole 20 24 used for peak calibration  
I 5 6:1 PEG-ald 5000 g/mole 20 5 
PEG mixed with reducing agent overnight, 
lower reaction speed 
J 5 6:1 PEG-ald 5000 g/mole 100 2 
PEG mixed with reducing agent overnight, 
no reaction 
K 5 6:1 PEG-ald 5000 g/mole 10 5 lower reaction speed 
L 5 6:1 PEG-ald 5000 g/mole 40 3 lower reaction speed 
M 5 6:1 PEG-ald 5000 g/mole 20 6 confirming reaction G and H 
N 10 6:1 PEG-ald 5000 g/mole 20 1 to high concentration 
P 7.5 8:1 PEG-ald 5000 g/mole 40 3 
test divided into 4 reactions, results used for 
kinetic calibration 
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Table 10.2: The table shows the parameters for all the SERC experiments. 
Experiment 
Lysozyme 
conc. (mg/ml) 
PEG mo-
lar ratio 
NaCNBH3 
conc. (mM) 
Flow 
(ml/min) 
Load 
(ml) 
Comments 
Q 7.5 8:1 40 0.3 0.5 
 
R 7.5 8:1 20 0.3 0.5 sampling 1ml from 16-23 ml confirming monoPEG conc. 
S1 7.5 8:1 20 0.3 0.1 
 
S2 7.5 8:1 20 0.3 0.2   
S3 7.5 8:1 20 0.3 0.3 
 
S4 7.5 8:1 20 0.3 0.4   
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Size Exclusion Reaction Chromatography  
Den nya tekniken för att förbättra processen av PEGylerade läkemedel
Dagens krav på läkemedel är höga, de 
ska t.ex. stanna kvar i kroppen under 
lång tid, ha lång hållbarhetstid och vara 
lätt att dosera. Att PEGylera ett läke-
medel kan ge dessa egenskaper. Idag är 
dock denna tillverkningsprocess lång-
sam och ger ett lågt utbyte. Size Exclus-
ion Reaction Chromatography (SERC) 
är en ny teknik som för-hoppningsvis 
ska förbättra denna process. 
Protein är idag vanligt förekommande som 
läkemedel. De är lätta att producera och 
kroppen har lätt för att ta åt sig medicinen. 
Nackdelen med dessa läkemedel är att 
kroppen med hjälp av bl.a. njurarna kan 
filtrera bort innan medicinen kan ge full 
effekt. Proteinen kan även ha korta håll-
barhetstider. Detta har forskarna löst ge-
nom att koppla på en lång kolkedja till 
proteinet. Denna kolkedja kallas för Poly-
EtylenGlykol (PEG) därav namnet 
PEGylering för själva processen. PEG till-
sammans med proteinet bildar en molekyl 
som inte filtreras bort av njurarna och där-
för kan stanna längre i kroppen. Molekylen 
blir även lättare att lösa upp i vatten samt 
att den får en bättre hållbarhetstid. 
Processen som används idag går ut på att 
PEG tillsammans med proteinet blandas i 
en satsreaktor där dessa får reagera under 
en längre tid. Resultatet av detta är att man 
får ut en viss del protein som inte har hun-
nit reagera, en del som har bildat rätt kom-
bination av en PEG-kedja och ett protein. 
Men det kommer även ut en del protein 
som kopplats samman med flera PEG-
kedjor, så kallat multiPEGylerat protein. 
Detta innebär att bara ca 60 % av proteinet 
som tillsätts till reaktorn kan användas som 
läkemedel. Resten (40 %) går direkt till 
papperskorgen då dessa molekyler inte är 
godkända av läkemedels-verket. 
För att undvika att få stora delar mul-
tiPEGylerat protein kan SERC-processen 
utnyttjas. SERC-processen använder sig av 
molekylernas storlek för att separera pro-
dukten innan en ny PEG-kedja kan kopplas 
ihop. En förstorad SERC-kolonn kan besk-
rivas som en cylinder fylld med inne-
bandy-bollar. Atomer representeras som 
sandkorn och molekyler t.ex. PEG och 
protein som mindre stenar. Stora molekyler 
som PEGylerade protein kan ses som stora 
stenar. Sandkorn och mindre stenar kan 
utan problem ta sig in i bollarnas hål. Re-
aktionen mellan PEG-kedjan och protein 
innebär att två små stenar bildar en stor. 
Eftersom sandkorn och små stenar kan röra 
sig fritt i cylindern tar dessa lång tid att ta 
sig igenom cylindern. De stora stenarna 
däremot kommer inte in i bollarna och kan 
därför bara röra sig mellan dessa. I och 
med detta kommer stora stenar att ta sig 
igenom cylindern mycket snabbare. 
PEG-kedjan tillsammans med proteinet 
kan under en längre tid reagera inne i 
SERC-kolonnen samtidigt som de trans-
porteras genom kolonnen. Produkten 
monoPEGylerat protein kan tack vare sin 
stora storlek förflytta sig snabbare genom 
kolonnen, och därmed undvika att PEG-
yleras en gång till. 
Resultatet av denna nya metod blir en pro-
cess som inte bara har möjligheten att 
minska mängden multiPEGylerade protein, 
utan även öka mängden användbart läke-
medel till ca 80 %. Till skillnad från en 
satsreaktor som behöver rena produkten 
från övriga ingredienser efter reaktionen, 
så sker detta redan inuti själva SERC-
kolonnen.  
 
